SCD and metabolic dysfunction-associated steatotic liver disease: Two HFD-fed rat models displayed a similar downregulation of Scd1 mRNA and protein levels, suggesting that SCD oligomer formation can alter enzyme activity and function, thus aggravating NAFLD (Fernández Gianotti et al., 2013).